OBJECTIVE AND TIMING OF DRUG DISPOSITION STUDIES .4. PHENYLBUTAZONE FORMULATIONS - INVITRO DISSOLUTION AND INVIVO PERFORMANCE

被引：8

作者：

LEESON, LJ

SHINAL, EC

LUKAS, G

ZAK, SB

WEINER, M

机构：

[1] CIBA GEIGY CORP,PHARM DIV,RES DEPT,ARDSLEY,NY 10502

[2] CIBA GEIGY CORP,PHARM DIV,RES DEPT,SUMMIT,NJ 07901

来源：

关键词：

D O I：

10.3109/03602537508993761

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：277 / 284

页数：8

共 8 条

[1]

[Anonymous], 1971, STAT PRINCIPLES EXPT

[2]

BURNS JJ, 1953, J PHARMACOL EXP THER, V109, P346

[3]

HOGDEN CAM, 1957, J PHARMACOL EXP THER, V120, P540

[4]

LEESON LJ, 1972, PHARMACOLOGY, V8, P154

[5] INFLUENCE OF ROUTE OF ADMINISTRATION ON DRUG AVAILABILITY [J].

ROWLAND, M .

WAGNER, JG .

[7]

Wagner JG, 1971, BIOPHARMACEUTICS REL

[8]

1970, US PHARMACOPOEIA, P934